Skip to main contentSkip to breadcrumbsSkip to sub navSkip to doormat

Christina Jäger wins Karl Landsteiner Prize 2026


18 Nov 2026

Christina Jäger, a PhD student in Joris van der Veeken's lab at the IMP, has been awarded the 2026 Karl Landsteiner Prize by the Austrian Society of Allergology and Immunology (ÖGAI). The honour recognises her research on regulatory T cells, published in Science Immunology, which revealed that these cells depend on their key regulator Foxp3 only during inflammation—uncovering a selective route to boost anti-tumour immunity.

The Austrian Society of Allergology and Immunology (ÖGAI) has awarded its 2026 Karl Landsteiner Prize to Christina Jäger, a PhD student in the lab of Joris van der Veeken. Jäger received the prize for her research on regulatory T cell regulation, published in Science Immunology in 2025, which revealed how the transcription factor Foxp3 supports T cells under inflammatory conditions—and how targeting this protein could help strengthen immune responses against tumours.

Regulatory T cells suppress immune responses to prevent excessive inflammation and autoimmunity, but can also limit the immune system's ability to attack tumours. Jäger's research focused on how Foxp3, a transcription factor central to the identity of regulatory T cells, sustains their function. Using a technique that rapidly and temporarily removes specific proteins in living mice, Jäger and colleagues depleted Foxp3 in mature regulatory T cells without disrupting their development.

The researchers found that regulatory T cells continued to function under healthy conditions, but required Foxp3 to maintain their identity during inflammation. In mouse models of cancer, removing Foxp3 throughout the body selectively impaired regulatory T cells within the inflammatory tumour environment. The scientists observed an enhanced anti-tumour immune response and slowed tumour growth, without detecting harmful inflammation in healthy tissues.

Jäger's work revealed how regulatory T cells' dependence on Foxp3 changes during inflammation, offering insight into how immune suppression in tumours might be reduced while preserving it in healthy tissues.

"Receiving this prize is a wonderful recognition of the work we did in the lab, and I am very grateful to the ÖGAI. It motivates me to pursue our open questions," says Jäger.

Jäger is now extending this work in the van der Veeken lab, investigating what happens to regulatory T cells when they lose Foxp3 during inflammation. She also aims to uncover the precise mechanisms by which Foxp3 controls gene expression in activated regulatory T cells.

About the Austrian Society of Allergology and Immunology

The Austrian Society of Allergology and Immunology (ÖGAI) represents scientists and physicians across Austria dedicated to investigating the physiology and pathophysiology of the immune system. Founded in 1970, the society promotes basic and translational research, supports training for early-career researchers and clinicians, and fosters dialogue between laboratory science and clinical practice in allergy and immunology.

About Christina Jäger

Christina Jäger studied Biology (B.Sc.) and Biochemistry and Biophysics (M.Sc.) at the Albert-Ludwigs-Universität Freiburg, Germany. Her master’s thesis focused on intracellular signalling in human B cells induced by a bacterial lectin. She joined Joris van der Veeken’s lab at the IMP in 2021, where she is completing her doctoral studies. Combining a genetically engineered mouse model for inducible protein degradation with transcriptomics and flow cytometry, she investigated whether regulatory T cells continuously depend on their lineage-defining transcription factor Foxp3. Her ongoing research examines Foxp3’s role in activated regulatory T cells and the consequences of its loss during inflammation.

Read more about the research

Lab of Joris van der Veeken